SCHEDULE 13G/A: Renaissance Technologies Discloses Passive Stake in Silo Pharma, Inc.

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have filed an amended Schedule 13G, disclosing a passive beneficial ownership of 0.84% in Silo Pharma, Inc.'s common stock as of December 31, 2024.

Summary

• Renaissance Technologies LLC (RTC) and Renaissance Technologies Holdings Corporation (RTHC) have filed an Amendment No. 1 to Schedule 13G regarding their ownership in Silo Pharma, Inc.
• As of December 31, 2024, the reporting persons collectively beneficially own 37,500 shares of Silo Pharma, Inc. Common Stock.
• This ownership represents 0.84% of the class of securities.
• Both RTC and RTHC hold sole voting power and sole dispositive power over all 37,500 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Silo Pharma, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of passive ownership and contains no information that would inherently sway sentiment positively or negatively regarding the issuer's performance or outlook.

Future Outlook

NA

Management Comments

• Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation certify that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing is a standard disclosure of passive institutional ownership, common across all industries for publicly traded companies when an entity's beneficial ownership crosses certain thresholds, providing transparency on significant shareholder positions.

Stakeholder Impact

• Shareholders receive transparency regarding the ownership structure of Silo Pharma, Inc. with the disclosure of Renaissance Technologies' passive stake.

Key Dates

Keywords

Silo Pharma Inc., Renaissance Technologies, Schedule 13G, Ownership Disclosure, Common Stock, Institutional Investment, Passive Stake